KiTZ Symposium 2019 Talks 10

Session 7
Michael Cox: Developing Inhibitors Against Rare Oncogenic Kinases
Mark Cowley: Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer
Pratiti (Mimi) Bandopadhayay: Cell-cycle and neuronal differentiation programs mediate response to BET-bromodomain inhibitors in MYC-driven medulloblastoma
Frank Westermann: Novel metabolic dependencies of MYCN-driven childhood neuroblastomas: Cyst(e)ine as a promising therapeutic target
Holger Lode: Passive GD2 directed immunotherapy upregulate the PD1/PD-L1 immune checkpoint in neuroblastoma: a rationale for combination therapy